EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Diagnostic and phylogenetic perspectives of the 2023 Murray Valley encephalitis virus outbreak in Australia: an observational study

Annaleise R Howard-Jones, Jackie E Mahar, Kate Proudmore, Grace I Butel-Simoes, John-Sebastian Eden, Matthew J Neave, Patrick Mileto, Linda Hueston, Kevin Freeman, Justin Ellem, Leon Caly, Chisha Sikazwe und 23 weitere

The Lancet Microbe · 2025-08 · 6 (8) · 101089

DOI: 10.1016/j.lanmic.2025.101089 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Lancet Microbe, 2025-08. Verfasst von Annaleise R Howard-Jones und 34 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology-Institute of Clinical Pathology and Medical Res…. Hauptthemen laut MEDLINE: Encephalitis Virus, Murray Valley, Disease Outbreaks, Encephalitis, Arbovirus, Phylogeny. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: An outbreak of Murray Valley encephalitis virus (MVEV), the largest since 1974, was observed in Australia between Jan 1 and July 31, 2023. This study aims to characterise the utility of diagnostic platforms, testing algorithms, and genomic characteristics of MVEV to facilitate a comprehensive framework for MVEV testing and surveillance in the outbreak setting. METHODS: In this observational study, we assessed flavivirus diagnostics for all patients with suspected Murray Valley encephalitis in Australia from Jan 1 to July 31, 2023. We included all patients with confirmed Murray Valley encephalitis, probable Murray Valley encephalitis, or acute unspecified flavivirus infection using the Communicable Diseases Network Australia case definition. Cases were excluded if an alternative diagnosis was identified. We collected blood, serum, cerebrospinal fluid, brain tissue, urine, or a combination of these samples, as appropriate and at the discretion of the treating clinician. We conducted multimodal diagnostic testing, which included flavivirus-specific serological and nucleic acid amplification testing. Metagenomic next-generation sequencing, including next-generation deep sequencing, target-enrichment, and targeted amplification, was conducted on human and representative mosquito-derived samples obtained from established mosquito population surveillance programmes for phylogenetic analysis. FINDINGS: 27 patients with encephalitis were assessed for MVEV between Jan 1, 2023, and July 31, 2023, 23 (85%) of whom fulfilled national case definitions for confirmed Murray Valley encephalitis. Patient ages ranged from 6 weeks to 83 years (median 62·0 years [IQR 31·0-67·5]) and patients were mostly male (21 [78%] male patients and six [22%] female patients). Incidence varied widely by geographical region and was highest in the Northern Territory (32·0 per 1 000 000 population). Diagnostic specimen collection generally occurred promptly (median 6·0 days [IQR 4·0-14·5] from symptom onset to diagnostic specimen collection). In seven patients, case assignation relied on convalescent serum samples to assess for seroconversion or an appropriate rise in antibody titre (to four times the initial value or greater), or both. MVEV-specific IgM was detectable in serum samples of 17 (81%) of 21 patients tested by day 7 and MVEV IgG or total antibody (TAb) were detected in 18 (100%) of 18 patients tested by day 30. MVEV-specific IgM (or TAb) and MVEV RNA were detected in cerebrospinal fluid collected within 14 days of symptom onset in nine (39%) of 23 patients and seven (28%) of 25 patients, respectively. Phylogenetic analysis revealed two circulating MVEV genotypes, G1A and G2, in mosquitoes and humans in 2023. In southeast Australia, only G1A was detected and probably introduced from enzootic foci in northern Australia. INTERPRETATION: This study provides a comprehensive overview of the diagnostic workflows and phylogenetic evaluations used during the 2023 MVEV outbreak in Australia, emphasising the importance of a multimodal approach for accurate and timely confirmation of flavivirus infection. Further One Health surveillance for MVEV and other zoonotic flaviviruses is key, given potential expanded ecological niches in the context of episodic climatic events. FUNDING: None.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalitis Virus, Murray ValleyDisease OutbreaksEncephalitis, ArbovirusPhylogenyHumansAustraliaMaleFemaleAdultMiddle AgedChildAdolescentChild, PreschoolAnimalsYoung AdultAgedHigh-Throughput Nucleotide SequencingInfantCulicidaeAntibodies, Viral

Substanzen

Antibodies, Viral

Autor:innen und Institutionen

  • Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW, Australia; Sydney Institute for…
  • CSIRO, Australian Centre for Disease Preparedness, Geelong, VIC, Australia.
  • Territory Pathology and Department of Microbiology, Royal Darwin Hospital, Darwin, NT, Australia.
  • Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, and Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, VIC…
  • Sydney Institute for Infectious Diseases, The University of Sydney, Sydney, NSW, Australia; Westmead Institute for Medical Research, Centre for Virus Research, Sydney, NSW, Australia.
  • Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology-Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW, Australia.

Zitieren

APA

Howard-Jones, A. R., Mahar, J. E., Proudmore, K., Butel-Simoes, G. I., Eden, J. S., Neave, M. J., Mileto, P., Hueston, L., Freeman, K., Ellem, J., Caly, L., Sikazwe, C., Levy, A., Thomas, A., Taylor, C., Kurucz, N., Smyth, K., Jennison, A., Moore, P., …, & Kok, J. (2025). Diagnostic and phylogenetic perspectives of the 2023 Murray Valley encephalitis virus outbreak in Australia: an observational study. The Lancet Microbe, 6(8), 101089. https://doi.org/10.1016/j.lanmic.2025.101089

Vancouver

Howard-Jones AR, Mahar JE, Proudmore K, Butel-Simoes GI, Eden JS, Neave MJ, et al. Diagnostic and phylogenetic perspectives of the 2023 Murray Valley encephalitis virus outbreak in Australia: an observational study. The Lancet Microbe. 2025;6(8):101089. doi:10.1016/j.lanmic.2025.101089

BibTeX
@article{HowardJones2025,
  author = {Howard-Jones, Annaleise R and Mahar, Jackie E and Proudmore, Kate and Butel-Simoes, Grace I and Eden, John-Sebastian and Neave, Matthew J and Mileto, Patrick and Hueston, Linda and Freeman, Kevin and Ellem, Justin and Caly, Leon and Sikazwe, Chisha and Levy, Avram and Thomas, Ashmitha and Taylor, Carmel and Kurucz, Nina and Smyth, Kirsten and Jennison, Amy and Moore, Peter and Wright, Rose and Mee, Peter T and Brischetto, Anna and Feldman, Rebecca and Dwyer, Dominic E and O'Sullivan, Matthew V and Mahony, Andrew A and Warner, Morgyn S and Papanicolas, Lito E and Schlebusch, Sanmarié and Lim, Chuan Kok and Baird, Robert and Speers, David and Williams, David T and Currie, Bart J and Kok, Jen},
  title = {Diagnostic and phylogenetic perspectives of the 2023 Murray Valley encephalitis virus outbreak in Australia: an observational study},
  journal = {The Lancet Microbe},
  year = {2025},
  volume = {6},
  number = {8},
  pages = {101089},
  doi = {10.1016/j.lanmic.2025.101089}
}
Kostenlos starten →